Loke J, Labopin M, Craddock C, Cornelissen JJ, et al. Additional cytogenetic features determines outcome in patients allografted for TP53 mutant acute myeloid leukemia. Cancer 2022 May 25. doi: 10.1002/cncr.34268.
PMID: 35612815